Baker McKenzie
2020-02-26 4:07 pm
| Sydney
The former CEO of Respiri has levelled a slew of claims at the ASX-listed medical technology company and two of its former directors, including breach of the Fair Work Act, as well as failure to pay short term incentives (STI) and vest options valued at $2.2 million.